NCT01947894

A Prospective Non-Interventional Study Protocol With Primary Data Collection - Assessment Of The Long Term Treatment Outcomes Of Genotropin Treatment In Growth Hormone Deficiency (GHD) Patients

SWEGHO - A PROSPECTIVE NON INTERVENTIONAL STUDY PROTOCOL WITH PRIMARY DATA COLLECTION - ASSESSMENT OF THE LONG TERM TREATMENT OUTCOMES OF GENOTROPIN TREATMENT IN GHD PATIENTS IN SWEDEN

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 377 (actual)
• Sponsor: Pfizer · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to assess the long term treatment outcomes of Growth Hormone treatment in patients who are prescribed and treated with Genotropin. Also, plan to determine the relationships between clinical status, dosage schedule and response to Genotropin treatment. This study will also contribute to our knowledge of adult Growth Hormone Deficiency, including transition period in Childhood Onset Growth Hormone Deficiency and its treatment.

Detailed description

Patients within inclusion criteria are asked to participate in the study.

Conditions

• Growth Hormone Deficiency

Interventions

Type	Name	Description
OTHER	Non Interventional Study	Non Interventional Study

Timeline

• Start date: 2013-11-20
• Primary completion: 2018-10-31
• Completion: 2018-10-31
• First posted: 2013-09-23
• Last updated: 2019-11-20
• Results posted: 2019-11-20

Locations

12 sites across 1 country: Sweden

Regulatory

• FDA-regulated drug study